tirzepatide weight loss vs semaglutide vs. Tirzepatide: What's the Difference and Which Is Right for You?: Envizion Medical: Wellness Center Tirzepatide vs Semaglutide: Which Weight
Description
Orthomolecular HiPhenolic- additional appetite control can be paired with semaglutide
The main differences in GLP-1 activity that have been found between males and females are: i) increased weight loss caused by the GLP-1 agonist, liraglutide, in women as compared with men (247)
Retatrutide is still in clinical trials and isnt available yet
GLP-1 therapies are moving beyond diabetes and obesity into MASH/NAFLD, cardiovascular risk reduction, and possibly neurodegenerative conditions
J Exp Med 2018
Tirzepatide received FDA approval as Mounjaro (type 2 diabetes) in May 2023 and as Zepbound (obesity) in November 2023
